Patterns of regulation of nuclear proto-oncogenes MYCN and MYB in retinoic acid treated neuroblastoma cells.
Thiele
C J
CJ
Molecular Genetics Section, National Cancer Institute, Bethesda, MD 20892.
D002454:Cell Differentiation / Q000187:drug effects*; D002460:Cell Line; D002648:Child; D003609:Dactinomycin / Q000494:pharmacology; D015972:Gene Expression Regulation, Neoplastic / Q000187:drug effects; D016259:Genes, myc / Q000187:drug effects*; D006801:Humans; D007700:Kinetics; D009447:Neuroblastoma / Q000235:genetics* / Q000473:pathology; D011505:Protein-Tyrosine Kinases / Q000235:genetics; D011518:Proto-Oncogene Proteins / Q000235:genetics*; D020598:Proto-Oncogene Proteins c-myb; D011519:Proto-Oncogenes / Q000187:drug effects*; D014212:Tretinoin / Q000494:pharmacology*
D011518:Proto-Oncogene Proteins; D020598:Proto-Oncogene Proteins c-myb; D003609:Dactinomycin; D014212:Tretinoin; D011505:Protein-Tyrosine Kinases